Indonesia vs Small island developing States (SIDS): Percentage of bloodstream infection due to Escherichia coli resistant
Indonesia
69.7%
in 2022
Small island developing States (SIDS)
50.0%
in 2022
Indonesia rank
8th
Small island developing States (SIDS) rank
8th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Indonesia
- Small island developing States (SIDS)
How they compare
Indonesia currently reports 69.7% against 50.0% in Small island developing States (SIDS), a difference of 19.7%.
That makes Indonesia's figure about 1.4 times Small island developing States (SIDS)'s.
Across all 5 years both countries report, Indonesia has been ahead every year.
Indonesia ranks 8th and Small island developing States (SIDS) ranks 8th of 50 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.0% | 45.9% | 25.2% | Indonesia |
| 2020s | 72.2% | 43.4% | 28.7% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Indonesia or Small island developing States (SIDS)?
- Indonesia, at 69.7% against 50.0% in Small island developing States (SIDS) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Indonesia and Small island developing States (SIDS)?
- 19.7%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Small island developing States (SIDS)?
- 5 years are reported by both, from 2018 to 2022.
- How do Indonesia and Small island developing States (SIDS) rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Indonesia ranks 8th and Small island developing States (SIDS) ranks 8th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.